Concept Medical Presents SirPAD PAD Findings at VIVA 2026
India, September 18, 2026 Concept Medical is highlighting new subgroup findings from the SirPAD randomized clinical trial that will...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
India, September 18, 2026 Concept Medical is highlighting new subgroup findings from the SirPAD randomized clinical trial that will...
SANTA ROSA, Calif., July 2, 2026 Endologix LLC announced the publication of 36-month results from its DETOUR2 clinical trial...
MIAMI, May 1, 2026 InspireMD, Inc. announced a voluntary U.S. recall of its CGuard® Prime 135 cm carotid stent...
TAMPA, Fla., March 30, 2026 Concept Medical Inc. (CMI) announced the primary results of the SirPAD randomized controlled trial,...
Plano, Texas — February 10, 2026: Vesalio, a global vascular intervention medical device company, announced major regulatory and commercial...
HANGZHOU, China and BERLIN, January 16, 2026 — Zylox-Tonbridge, a Hong Kong–listed medical technology company focused on neurovascular and...
